Authors: Solange Moll, Martin Ebeling, Franziska Weibel, Annarita Farina, Andrea Araujo Del Rosario, Jean Christophe Hoflack, Silvia Pomposiello, Marco Prunotto
DOI: 10.1371/journal.pone.0056575
Abstract Summary
New research reveals that injured kidney epithelial cells can trigger fibroblast activation, driving kidney scarring. Using a 3D cell culture model, scientists showed that cisplatin-damaged tubular cells prompted fibroblasts to become myofibroblasts—key players in fibrosis. This challenges traditional views and positions epithelial cells as promising targets for anti-fibrotic therapies.
Why Brain? đź§
Injured kidney epithelial cells can trigger fibroblast activation into myofibroblasts, driving fibrosis. This finding suggests epithelial cells are key therapeutic targets for preventing kidney scarring.
The image is AI-generated for illustrative purposes only. Courtesy of Midjourney.